BACKGROUND: Many national guidelines and references have been developed for the reduction of
Clostridium difficile Infection (CDI) and establishing and/or improving antimicrobial stewardship. Outcome
measures were readily available through the National Healthcare Safety Network (NHSN)
to demonstrate improvement in CDI. However, there were no national recommended measures
or data bases for tracking improvement in antibiotic usage. For our work, it was decided
that daily defined doses (DDD) of fluoroquinolones would be used as a measure to show
improvement in hospitals' antibiotic stewardship programs (ASP) in this association's
collaborative.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
